Wilson Sonsini Goodrich & Rosati advised Warburg Pincus on the transaction. New Frontier Healthcare/United Family Healthcare (UFH), a leading high-end private healthcare services company in China,...
You must be a Standard 1 Year member to access this content.
Cooley advised Vivace Therapeutics, Inc., and Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics on the patent matters related to the transaction. Vivace Therapeutics, Inc. announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Flock Safety on the transaction. Flock Safety, the leading safety technology platform helping communities thrive, announced a $275 million fundraise...
You must be a Standard 1 Year member to access this content.
White & Case served as legal advisors to Azurity, and Wilson Sonsini Goodrich & Rosati advised Azurity on litigation matters related to the transaction. Reed Smith...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Terabase Energy on the transaction. Terabase Energy (Terabase), a leader in digital and automation solutions for utility-scale solar power, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Enter on the transaction. Enter (formerly Talisman), a brazilian start-up that is using artificial intelligence to help large companies with...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Alianza on the transaction. Alianza, Inc., the world’s first cloud-orchestrated, AI-powered communications platform dedicated to service providers, announced the completion...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Urgent.ly on the transaction. Urgent.ly, a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings, Platanus, and Pureos Bioventure, as investors on the transaction. Callio Therapeutics, a biotechnology company focused on realizing the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Marqeta on the transaction. Marqeta, the global modern card issuing platform that enables embedded finance solutions for the world’s innovators,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IonQ on the offering, and Paul, Weiss, Rifkind, Wharton & Garrison advised the sales agents. IonQ, Inc. (NYSE: IONQ), a...
You must be a Standard 1 Year member to access this content.
IonQ was advised by Wilson Sonsini Goodrich & Rosati, Homburger AG and ArentFox Schiff on the deal. IonQ (NYSE: IONQ), a leader in the quantum computing...
You must be a Standard 1 Year member to access this content.
